EP-0015

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameEP-0015
Drug Alias NameDirected Prodrug Therapy (Incanthera)smart bombICT01-2588EP-0015ICT-2588
ClassificationNatural product/ExtractSmall molecules > Prodrug > Directed prodrug therapy
Mechanisms of ActionMatrix metalloproteinase modulators
TargetsMatrix metalloproteinase
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsLung Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bradford
China Registration ClassN/A

Develop Information

Active CompaniesIncanthera Research & Development LtdEllipses Pharma Ltd
Inactive CompaniesUniversity Of Bradford
Active IndicationsSolid tumoursProstatic NeoplasmsLung Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A